# Merit Medical (MMSI) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/MMSI
## Company Profile
- Ticker: MMSI
- Exchange: NASDAQ
- Sector: MedTech
- Location: United States
- Tags: MedTech, Oncology
## Stock Data
- Close: 87.21 USD
- Market cap: 3632384120.95 USD
- Last updated: 2026-10-09
## Business Overview
### Diversified Interventional MedTech Company
Merit Medical is a global manufacturer and marketer of healthcare technology, with a broad product portfolio used across interventional and procedural medicine. Its business is driven by recurring device demand, product category breadth, international distribution, and execution in hospital and outpatient settings.
### Broad Product Category Exposure
The company sells into multiple medical device categories rather than relying on one franchise. Its second-quarter results highlighted improving growth trends across the global business, with particular strength in the U.S. market. This diversified structure gives Merit exposure to several procedure-driven revenue streams and reduces dependence on a single product launch.
### Margin and Operating Discipline
Merit is executing against its Continued Growth Initiative, with emphasis on organic revenue growth, profitability improvement, and cash generation. In the second quarter of 2026, the company expanded both GAAP and non-GAAP margins while delivering 9% organic constant-currency revenue growth.
### Strategic Position
Merit is best understood as a scaled, diversified interventional device company. Its differentiation comes from breadth, procedure exposure, and operational discipline rather than a single breakthrough technology. Near-term performance depends on maintaining organic growth, improving profitability, and converting strategic planning into sustainable long-term expansion.
## Why The Stock Is Moving

As of Oct 9, 2026, MMSI closed up 2.30% at $87.21. No new same-company headline was identified in the current news window.

## Recent News
- 2026-10-06 20:30 EST — [Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026](https://biopharmsignal.com/news/MMSI/merit-medical-systems-to-announce-third-quarter-2026-results-on-october-29-2026-9a832317) — Source: Merit Medical
- 2026-09-04 13:25 EST — [Merit Medical to Participate in Upcoming Investors Conferences in September](https://biopharmsignal.com/news/MMSI/merit-medical-to-participate-in-upcoming-investors-conferences-in-september-5d8f9ba8) — Source: Merit Medical
- 2026-08-19 20:05 EST — [Merit Medical Announces Global Operations Leadership Transition](https://biopharmsignal.com/news/MMSI/merit-medical-announces-global-operations-leadership-transition-97825d2e) — Source: Merit Medical
- 2026-08-05 16:00 EST — [Merit Medical to Participate in Upcoming Investors Conferences in August](https://biopharmsignal.com/news/MMSI/merit-medical-to-participate-in-upcoming-investors-conferences-in-august-59f5c518) — Source: Merit Medical
- 2026-07-30 20:05 EST — [Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance](https://biopharmsignal.com/news/MMSI/merit-medical-reports-second-quarter-2026-results-and-updates-full-year-2026-gui-fefcae97) — Source: Merit Medical